Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Corporate Presentation services provided by Seqens

Seqens
Corporate Presentation

PDF Upload Dec, 2022

Seqens Names Pascal Villemagne as CEO

19 Feb 2025

// PRESS PHARMA

Seqens Personal Care Launches Biobased Caprylyl Glycol For Beauty

01 Jan 2025

// PRESS RELEASE

SEQENS Unit Joins Smart Immune for Clinical Batch Making

03 Dec 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Seqens VB RM

Contact Supplier

CPhI North America

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/pXubPairWIw

Xls

CATEGORY PAGE

Seqens

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2025, Products Under Development 2025, Intermediates Product List 2023, Corporate Presentation, European Industry Summit 2024, GMP Certificate 2024, CDMO Brochure, Drug Delivery Solutions

Product List 2025
Products Under Development 2025
Intermediates Product List 2023
Corporate Presentation
European Industry Summit 2024
GMP Certificate 2024
CDMO Brochure
Drug Delivery Solutions

VIDEO(s)

Corporate Video 2024, Devens R&D Center Opening - Boston'Lab, New HPAPI Unit in Aramon (France), CELLforCURE, Essential Drug Substances, Motion RD, Who is SEQENS?

Corporate Video 2024
Devens R&D Center Opening - Boston'Lab
New HPAPI Unit in Aramon (France)
CELLforCURE
Essential Drug Substances
Motion RD
Who is SEQENS?

DIGITAL CONTENT

2 Interview #SpeakPharma, 15 Corporate Content #SupplierSpotlight, 5 Data Compilation #PharmaFlow, 65 News #PharmaBuzz

2 Interview #SpeakPharma
15 Corporate Content #SupplierSpotlight
5 Data Compilation #PharmaFlow
65 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

124 All APIs, 52 USDMF, 38 CEP/COS, 17 JDMF, 13 KDMF, 47 NDC API, 2 VMF, 68 Listed APIs

124 All APIs
52 USDMF
38 CEP/COS
17 JDMF
13 KDMF
47 NDC API
2 VMF
68 Listed APIs

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

KEY PRODUCTS

Baclofen, Cisatracurium Besylate, Clascoterone, Fluralaner, Fluticasone Furoate, Fluticasone Propionate, Glycopyrronium Bromide, Glycopyrronium Tosylate, Ketamine Hydrochloride, Methimazole, Midazolam, Midazolam Hydrochloride, Midazolam Maleate, Olopatadine Hydrochloride, Remimazolam Besylate, Rotigotine, Sparsentan, Vamorolone, Varenicline Tartrate

Baclofen
Cisatracurium Besylate
Clascoterone
Fluralaner
Fluticasone Furoate
Fluticasone Propionate
Glycopyrronium Bromide
Glycopyrronium Tosylate
Ketamine Hydrochloride
Methimazole
Midazolam
Midazolam Hydrochloride
Midazolam Maleate
Olopatadine Hydrochloride
Remimazolam Besylate
Rotigotine
Sparsentan
Vamorolone
Varenicline Tartrate

SERVICES

Analytical, API Manufacturing, API & Drug Product Development

Analytical
API Manufacturing
API & Drug Product Development
- 3 Preformulation & Material Science
- 14 API Development

KEY SERVICES

Contract API Manufacturing Services, API Custom Synthesis & Manufacturing, HPAPI Contract Manufacturing, API Spray Drying Services

Contract API Manufacturing Services
API Custom Synthesis & Manufacturing
HPAPI Contract Manufacturing
API Spray Drying Services

EXCIPIENTS

4 All Excipients, 4 USDMF, 5 Listed Products

4 All Excipients
4 USDMF
5 Listed Products

EXCIPIENTS BY INGREDIENTS

Poly-DL-Lactic-co-Glycolic Acid, Poly lactic acid, Poly caprolactone

Poly-DL-Lactic-co-Glycolic Acid
Poly lactic acid
Poly caprolactone

EXCIPIENTS BY APPLICATIONS

Parenteral

Parenteral

INSPECTIONS & REGISTRATIONS

29 FDA, 31 EDQM, 9 GDUFA

29 FDA
31 EDQM
9 GDUFA

PI73283

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!